Login / Signup

Limited utility of novel serological biomarkers in patients newly suspected of having giant cell arteritis.

Anthony Michael SammelMeilang XueElisabeth KarstenChristopher B LittleSusan SmithKatherine NguyenRodger Laurent
Published in: International journal of rheumatic diseases (2021)
This study did not identify new serological biomarkers to assist in diagnosing or assessing the vasculitis burden in GCA.
Keyphrases
  • giant cell
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • pulmonary embolism
  • risk factors